KUOPIO CENTER FOR GENE AND CELL THERAPY (KCT)
Kuopio Center for Gene and Cell Therapy (KCT) is a research center that provides basic and translational research in Gene and Cell Therapy. To create innovative therapeutics, professional staff and laboratories with cutting-edge devices provide scientific know-how and sophisticated technologies. It was founded in 2018 and is based in Kuopio, Eastern Finland.
KUOPIO CENTER FOR GENE AND CELL THERAPY (KCT)
Industry:
Genetics Product Research Therapeutics
Founded:
2018-01-01
Address:
Kuopio, Eastern Finland, Finland
Country:
Finland
Website Url:
http://www.kct.fi
Total Employee:
11+
Status:
Active
Contact:
+358 44 7840 560
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
Oxford BioMedica
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research.
Current Employees Featured
Official Site Inspections
http://www.kct.fi Semrush global rank: 8.46 M Semrush visits lastest month: 306
- Host name: thunder.cloudcity.fi
- IP address: 185.220.77.10
- Location: Finland
- Latitude: 60.1717
- Longitude: 24.9349
- Timezone: Europe/Helsinki
More informations about "Kuopio Center for Gene and Cell Therapy (KCT)"
About Us | Ferring Ventures Oy - kct.fi
About Us. We are a limited company based in Kuopio, Finland that was founded in 2017. We undertake pioneering high-quality basic and translational research in the new and exciting โฆSee details»
Home | Ferring Ventures Oy - The foundation for advanced therapies
Nov 22, 2021 About us. We are a world-renowned research company located in Kuopio, Finland, in the heart of Savo. Our mission is to conduct high-level research on the translational field of โฆSee details»
Gene therapy - KCT
Our goal in vector development programs is to develop safer, regulated and more efficient viral vectors. An understanding of disease at the molecular biology level is key to the way KCT โฆSee details»
Kuopio Center for Gene and Cell Therapy (KCT) | LinkedIn
Kuopio Center for Gene and Cell Therapy (KCT) | 1,527 followers on LinkedIn. KCT is a world-renowned research company conducting high-level research on translational fields of gene and cell therapy | Kuopio Center for Gene and Cell โฆSee details»
Welcome to the Kuopio Center for Gene and Cell Therapy
Kuopio Center for Gene and Cell Therapy (KCT) - Crunchbase
Contact Email [email protected]; Phone Number +358 44 7840 560; Kuopio Center for Gene and Cell Therapy (KCT) is a research center that provides basic and translational research in Gene โฆSee details»
Ferring Ventures Oy | LinkedIn
Ferring Ventures Oy | 1 851 followers on LinkedIn. We are a world-renowned research company conducting high-level research on translational fields of cell therapy | Ferring Ventures Oy is a โฆSee details»
Presenting Kuopio Health members: KCT has expertise โฆ
Aug 17, 2021 KCT was incorporated in 2017 and currently employs slightly over 40 people and its annual turnover is between EUR 5 and 6 million. The company aims at developing new forms of treatment. During its first years of operation, โฆSee details»
KCT:llä on positiivinen tekemisen draivi - Business Kuopio
Jun 11, 2019 Etusivu » KCT:llä on positiivinen tekemisen draivi. KCT:llä on positiivinen tekemisen draivi. 11.6.2019. Yrityshistorian saavutuksissa mitattuna geeni- ja soluterapian tutkimuskeskus KCT on ottanut vasta taaperon โฆSee details»
Kuopioon kansainvälinen geeni- ja soluterapian โฆ
Apr 27, 2018 KCT-tutkimuskeskuksen taustalla ovat geeniterapian uranuurtajat, akatemiaprofessori Seppo Ylä-Herttuala Itä-Suomen yliopiston A.I. Virtanen -instituutista ja FinVectorin hallituksen jäsen Nigel Parker. FinVectorin toiminta โฆSee details»
Positive drive at KCT - Business Kuopio
Jun 24, 2019 Home » Positive drive at KCT. Positive drive at KCT. 24.6.2019. In terms of achievements in the companyโs history, the Kuopio Center for Gene and Cell Therapy KCT may seem like a toddler taking its first steps, but the โฆSee details»
Our competences | Ferring Ventures Oy - KCT
Analytics. Accurate and advanced analytics is an essential core capability in the ATMPs area. Our Analytical team provides โstate of the artโ analytical capabilities to support daily routine โฆSee details»
University of Eastern Finland and Ferring Ventures to continue ...
Nov 22, 2021 Scientific Director Tuija Kekarainen, Kuopio Center for Gene and Cell Therapy Oy, tuija.kekarainen (a) kct.fi The A.I. Virtanen Institute for Molecular Sciences is a research โฆSee details»
Kuopio Center for Gene and Cell Therapy (KCT) Information
Kct.fi; Igor Oruetxebarria Senior Scientist at Kuopio Center for Gene and Cell Therapy (KCT) Finland View. 1 kct.fi; View Similar People. Related Companies Miradore. 66 $5.4m Klevu. โฆSee details»
Kuopio Center for Gene and Cell Therapy (@we_are_kct) - Instagram
263 Followers, 47 Following, 128 Posts - Kuopio Center for Gene and Cell Therapy (@we_are_kct) on Instagram: "We are Forcing new Frontiers in Molecular Medicine ๏งฌ ๏ธ"See details»
Cell therapy - KCT
Cell therapy. COMPETENCE & ECOSYSTEM. The research of the Cell Therapy team focuses on innovative cell therapies and ex vivo cell editing. Researchers are working on developing โฆSee details»
Adriana Abizadeh - Executive Director - LinkedIn
The KCT supports sustainable corridor development through thoughtful real estate acquisition, community engagement, broad local ownership, small business lending and technical โฆSee details»
Hallitus päättää keskusjärjestötason asioista ja jaostot sopimuksista
[email protected]. Lisää aiheesta. Tiedote. 12.11.2024. Työnantajajärjestö Avainta lopettaa toimintansa โ jo lähes 250 yritystä on siirtynyt KT:n jäseniksi. Avaintan lakkautuspäätös โฆSee details»
Category: Publications - KCT
Minna Sivonen, Katja A Sirviö, Sara Wojciechowski, Anssi Kailaanmäki, Satu Kaipainen, Aubrey Bailey, Martin Villalba, Tuija Kekarainen. Cytokines impact natural killer cell phenotype and โฆSee details»
Category: News - KCT
Ferring Ventures SA is the owner of both KCT Oy and FinVector Oy. The research collaboration with the University of Eastern Finland is strongly focused on the National Virus Vector โฆSee details»